Sorafenib Rechallenge and Sorafenib after Lenvatinib Failure in a Patient with Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2021 at "Internal Medicine"
DOI: 10.2169/internalmedicine.5552-20
Abstract: A 70-year-old man was diagnosed with multiple lung metastases from hepatocellular carcinoma, and lenvatinib was initiated. Three months later, the response was progressive disease. Sorafenib therapy as a second-line drug was started. Three months later,… read more here.
Keywords: hepatocellular carcinoma; sorafenib rechallenge; sorafenib; failure patient ... See more keywords